Dexcom ONE in insulin-treated #T1D & #T2D
🔹 HbA1c⤵️ at 6m: T1D (-12 mmol/mol) & T2D (-18)
🔸 TIR⤴️ in T2D (+9%) = 2.2h/day in range
🔹 Diabetes distress ⤵️ (71%→42% in T1D, 51%→31% in T2D)
🔸 🎯 for deprived areas (41% T2D in lowest SES quintile)
👉 Works in deprived area🇬🇧❗️
🔗 ggdocs.co/tpevdz
ggdocs.co
<em>Diabetic Medicine</em> | Diabetes UK Journal | Wiley Online Library
Aims This study assessed real-world glycaemic outcomes associated with the use of Dexcom ONE in adults with suboptimally controlled diabetes. Methods In this single-site prospective study, adults ...